These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 26229753)

  • 41. Insights from VERIFY: Early Combination Therapy Provides Better Glycaemic Durability Than a Stepwise Approach in Newly Diagnosed Type 2 Diabetes.
    Matthews D; Del Prato S; Mohan V; Mathieu C; Vencio S; Chan JCN; Stumvoll M; Paldánius PM
    Diabetes Ther; 2020 Nov; 11(11):2465-2476. PubMed ID: 32975711
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative evaluation of efficacy and safety of combination of metformin-vidagliptin versus metfromin-glimepiride in most frequently used doses in patients of type 2 diabetes mellitus with inadequately controlled metformin monotherapy-A randomised open label study.
    Gupta S; Khajuria V; Tandon VR; Mahajan A; Gillani ZH
    Perspect Clin Res; 2015; 6(3):163-8. PubMed ID: 26229753
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
    Hermansen K; Kipnes M; Luo E; Fanurik D; Khatami H; Stein P;
    Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial.
    Umpierrez G; Issa M; Vlajnic A
    Curr Med Res Opin; 2006 Apr; 22(4):751-9. PubMed ID: 16684436
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of glimepiride/metformin fixed-dose combination vs metformin uptitration in type 2 diabetic patients inadequately controlled on low-dose metformin monotherapy: A randomized, open label, parallel group, multicenter study in Korea.
    Kim HS; Kim DM; Cha BS; Park TS; Kim KA; Kim DL; Chung CH; Park JH; Jang HC; Choi DS
    J Diabetes Investig; 2014 Nov; 5(6):701-8. PubMed ID: 25422771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glycemic effects of vildagliptin and metformin combination therapy in Indian patients with type 2 diabetes: an observational study.
    Chatterjee S; Chatterjee S
    J Diabetes; 2014 May; 6(3):237-42. PubMed ID: 23879210
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Profile of vildagliptin in type 2 diabetes: efficacy, safety, and patient acceptability.
    Pan C; Wang X
    Ther Clin Risk Manag; 2013; 9():247-57. PubMed ID: 23818788
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus.
    Ved P; Shah S
    Indian J Endocrinol Metab; 2012 Mar; 16 Suppl 1(Suppl1):S110-3. PubMed ID: 22701828
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and tolerability of vildagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes mellitus.
    Pan C; Xing X; Han P; Zheng S; Ma J; Liu J; Lv X; Lu J; Bader G;
    Diabetes Obes Metab; 2012 Aug; 14(8):737-44. PubMed ID: 22369287
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Standards of medical care in diabetes--2012.
    American Diabetes Association
    Diabetes Care; 2012 Jan; 35 Suppl 1(Suppl 1):S11-63. PubMed ID: 22187469
    [No Abstract]   [Full Text] [Related]  

  • 52. Comparison of vildagliptin-metformin and glimepiride-metformin treatments in type 2 diabetic patients.
    Jeon HJ; Oh TK
    Diabetes Metab J; 2011 Oct; 35(5):529-35. PubMed ID: 22111045
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of vildagliptin as add-on therapy to a low-dose metformin.
    Filozof C; Schwartz S; Foley JE
    World J Diabetes; 2010 Mar; 1(1):19-26. PubMed ID: 21537424
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of short-term intensive therapy with glimepiride and metformin in newly diagnosed type 2 diabetic patients].
    WANG M; GAO F; XUE YM; HAN YJ; FU XJ; HE FY
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Mar; 31(3):564-6. PubMed ID: 21421509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. When metformin fails in type 2 diabetes mellitus.
    Esposito K; Bellastella G; Giugliano D
    Arch Intern Med; 2011 Feb; 171(4):365-6. PubMed ID: 21357815
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.